Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results from a multicentre randomized controlled trial:the SCAT trial by Rogers, Chris et al.
                          Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P., ...
Ascione, R. (2017). Shortening cardioplegic arrest time in patients
undergoing combined 5 coronary and valve surgery: results from a
multicentre randomized controlled trial: the SCAT trial. European Journal of
Cardio-Thoracic Surgery, [ezx087]. DOI: 10.1093/ejcts/ezx087/3750612
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1093/ejcts/ezx087/3750612
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Oxford University
Press at https://academic.oup.com/ejcts/article-lookup/doi/10.1093/ejcts/ezx087. Please refer to any applicable
terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Supplementary data 
Statistical Methods—Further Details 
When analyzing myocardial troponin T (cTnT) release, the baseline and posttreatment values 
were modelled jointly to avoid having to exclude or impute cases with missing baseline 
measures. Similarly, when analysing measures of ischaemic stress assessed in the myocardial 
biopsies, the measurement taken 5 minutes following CPB institution (control biopsy) was 
modelled jointly with the reperfusion biopsy taken 10 minutes after releasing the cross clamp.  
When analysing intubation time, and length of stay outcomes, any patient who died prior to 
the event was treated as a censored observation.  
 
 
Table E1 Protocol deviations 
 
 
Randomised to 
Conventional 
group (n=84) 
Randomised to 
Hybrid group 
(n=81) 
Overall 
(n=165) 
 n % n % n % 
Any protocol deviations 8 9.5% 2 2.5% 10 6.1% 
Randomised but not treated 4 4.8% 1 1.2% 5 3.0% 
 
Treated in 
Conventional 
group (n=80) 
Treated in  
Hybrid group 
(n=80) 
Overall 
(n=160) 
 n % n % n % 
Did not meet eligibility criteria 1 1.3% 0 0.0% 1 0.6% 
Did not receive allocated 
treatment 
0 0.0% 1 1.3% 1 0.6% 
Only received CABG 3 3.8% 0 0.0% 3 1.9% 
Only received valve 0 0.0% 0 0.0% 0 0.0% 
 
 
  
Table E2 Details of protocol deviations where available 
Allocation Centre Further details  
Randomised but not treated 
Conventional A  Patient had porcelain aorta, operation did not proceed 
Conventional B Patient consented and withdrew prior to surgery 
Conventional B Only received AVR only 
Conventional B  Patient withdrew consent so data not collected 
Hybrid C   During Pre-operative period Pulmonary Artery pressure was found 
to be higher than systemic pressure, with Right Ventricular pressure 
being 110mmHg. In view of these findings surgery was not carried 
out given the extremely high risk associated with this condition. 
Did not meet eligibility criteria 
Conventional B Creatinine level was 176 µm/l 
Did not receive allocated treatment 
Hybrid A The patient had conventional surgery as the surgeon was not 
comfortable with the available cardiac stabiliser 
Only received CABG 
Conventional A Reason was not given on study case report form 
Conventional A Porcelain aorta. 
Conventional A  Intra-operative echocardiogram showing only mild valvular disease. 
 
  
Table E3 Withdrawals 
 
 
 
  
 
Randomised to 
Conventional 
surgery (n=84) 
Randomised to 
Hybrid surgery 
(n=81) Overall (n=165) 
 n % n % n % 
Any withdrawal 4 5% 1 1% 5 3% 
Time of 
withdrawal 
Pre-op 2  1  3  
Intra-op 2  0  2  
Decision taken by Patient 2  0  2  
 Clinician 2  1  3  
Reason for 
withdrawal 
Surgery not needed 0  1  1  
Operation aborted 1  0  1  
Only CABG needed  1  0  1  
Reason unknown 2  0  2  
Table E4 Intra-operative characteristics, additional information 
 
 
 
Conventional 
(n=80) 
Hybrid  
(n=80) 
Overall  
(n=160) 
 n % n % n % 
Operation time (mins) (Median, IQR) 288 (220, 403) 300 (245, 405) 297 (230, 403) 
Lowest HCT (Mean, SD) 23.5 4.12 22.4 3.77 23.0 3.97 
Lowest temperature (C) (Median, IQR) 30.0 (28.0, 32.0) 30.2 (28.0, 32.0) 30.0 (28.0, 32.0) 
No sinus rhythm on cross clamp removal 36  46.3% 21 26.5% 57 35.6% 
 AV Block 19 24.4% 14 17.6% 33 20.8% 
 Atrial fibrillation 8 10.3% 3 3.8% 11 7.0% 
 Ventricular fibrillation 7 9.0% 3 3.8% 10 6.3% 
 Junctional rhythm 2 2.6% 1 1.3% 3 1.9% 
DC Cardioversion 16 20.0% 10 12.5% 26 16.3% 
 
Intra-operative IABP 
 
5 
 
7.1% 
 
4 
 
5.4% 
 
9 
 
6.3% 
 Duration (hrs) (Median, IQR) 3.0 (3.0, 5.0) 19.8 (2.8, 65.5) 3.5 (3.0, 36.0) 
Intra-operative transfusion requirements1       
 RBC (Products, Patients) 109 42 119 46 228 88 
 FFP (Products, Patients) 16 7 25 12 41 19 
 Platelets (Products, Patients) 59 22 81 30 140 52 
 
 
1 Data on all transfusions given, either intraoperatively or postoperatively, are reported in 
Table E5.HCT haematocrit; IQR inter-quartile range; AV Atrio-ventricular; DC Direct 
Current; RBC Red Blood Cells; FFP Fresh Frozen Plasma; IABP intra-aortic balloon pump; 
IQR interquartile range; GTN glyceryl trinitrate; SNP sodium nitroprusside. Missing data 
(conventional, hybrid): Lowest HCT, Lowest core temperature, Rhythm on clamp removal: 2 
(2, 0).  
       
Table E5 secondary outcomes 
 
 
Conventiona
l  (n=80) 
Hybrid  
(n=80) 
OR/HR 
GMR  
(95% CI) P-value 
 n % n %   
INTRA-OP OUTCOMES       
Duration of CPB (mins) (Median, IQR) 142 (105, 195) 153 (115, 
233) 
GMR=1.07  
(0.98, 1.16) 
0.120 
Duration of CA (mins) (Median, IQR) 98 (79, 135) 89 (63, 
118) 
GMR=0.84 
(0.77, 0.93)  
0.0004 
INTRA-OP/POST-OP TRANSFUSION       
Any transfusion requirement 66 82.5% 65 82.3% OR= 0.87 
(0.35, 2.18) 
0.773 
 Red blood cells (units, patients) 222 65 249 62   
 Fresh frozen plasma (units, patients) 72 17 80 23   
 Platelets (units, patients) 120 28 143 33   
 Cryoprecipitate (units, patients) 4 2 10 3   
POST-OP COMPLICATIONS       
Any subsystem organ complication 44 55.0% 51 63.8% OR= 1.49  
(0.72, 3.08) 
0.279 
 Cardiovascular 39 48.8% 39 48.8%   
 Pulmonary 9 11.3% 10 12.5%   
 Infective 13 16.3% 14 17.5%   
 Renal 5 6.3% 6 7.5%   
 Gastrointestinal 2 2.5% 5 6.3%   
 Neurological 2 2.5% 8 10.0%   
  
Conventiona
l  (n=80) 
Hybrid  
(n=80) 
OR/HR 
GMR  
(95% CI) P-value 
 n % n %   
Low cardiac output1 29 36.3% 26 32.5% OR= 0.84  
(0.39, 1.79) 
0.649 
Blood loss  (12 hours post-op; ml) (Median, 
IQR) 
363 (228, 
615) 
400 (245, 
600) 
GMR= 0.96 
(0.78, 1.18) 
0.696 
Extubation time (hours) (Median, IQR)2 16.
5 
(7.6, 
24.9) 
17.1 (7.1, 
51.3) 
HR=0.93 
(0.68, 1.29) 
0.668 
ICU stay (hours) (Median, IQR)3 51.
3 
(22.7, 
121.0) 
67.5 (23.5, 
122.2) 
HR=0.93 
(0.66,1.30)  
0.667 
Hospital stay (days) (Median, IQR) 10.
0 
(7.0, 
14.0) 
9.0 (8.0, 
13.0) 
HR=0.97 
(0.69, 1.35) 
0.852 
1 Defined as adrenaline, dopamine, dobutamine or enoximone (at a dose of ≥ 5ug/kg/min) or 
IABP given consecutively to patient for 3 hours or more; 2Includes any re-intubation (number 
of re-intubations in conventional group=7, in hybrid group=8); 3 Includes any readmission 
(number of readmissions in conventional group=1, in hybrid group=0); ICU= intensive care 
unit; IABP= intra-aortic balloon pump. Missing data (conventional, hybrid): Duration of 
cardiopulmonary bypass, Duration of aortic cross clamp: 2 (2, 0). Transfusion requirements: 
1 (0, 1).   
Figure E1 Intubation time (A), intensive care (B) and hospital stay (C) by group 
(A) Intubation time    (B) Stay in cardiac intensive care 
 
 
 
 
 
 
(B) Stay in hospital 
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Table E6 In-hospital adverse events 
 
Randomised to  
Conventional surgery 
 (n=80) 
Randomised to  
Hybrid surgery  
(n=80) 
Overall  
(n=160) 
 Events Patients %1 Events Patients %1 Events Patients %1 
CARDIAC COMPLICATIONS 49 39 49% 43 39 49% 92 78 49% 
Post-operative MI 1 1 1% 0 0 0% 1 1 1% 
Any arrhythmias 42 37 46% 36 36 45% 78 73 46% 
 SVT/AF  39 37 46% 35 35 44% 74 72 45% 
 VF/VT  3 3 4% 0 0 0% 3 3 2% 
 Other 0 0 0% 1 1 1% 1 1 1% 
PULMONARY COMPLICATIONS 15 9 11% 14 10 13% 29 19 12% 
Re-intubation 4 4 5% 6 6 8% 10 10 6% 
Tracheostomy 4 4 5% 3 3 4% 7 7 4% 
Mask CPAP 6 6 8% 5 5 6% 11 11 7% 
ARDS 1 1 1% 0 0 0% 1 1 1% 
INFECTIVE COMPLICATIONS 16 13 16% 19 14 18% 35 27 17% 
Septicaemia 2 2 3% 2 2 3% 4 4 3% 
Chest infection 11 10 13% 14 14 18% 25 24 15% 
Sternotomy infection 3 3 4% 3 1 1% 6 4 3% 
RENAL COMPLICATIONS 5 5 6% 7 6 8% 12 11 7% 
Need for haemofiltration/dialysis 5 5 6% 7 6 8% 12 11 7% 
GI COMPLICATIONS 2 2 3% 6 5 6% 8 7 4% 
Peptic ulcer/ GI bleed/ Perforation 1 1 1% 3 3 4% 4 4 3% 
Other GI (e.g. bowel obstruction) 1 1 1% 3 3 4% 4 4 3% 
CEREBRAL COMPLICATIONS 2 2 3% 9 8 10% 11 10 6% 
Stroke 1 1 1% 2 2 3% 3 3 2% 
Transient Ischaemic Attack  0 0 0% 2 2 3% 2 2 1% 
Coma or confusion state 2 2 3% 5 4 5% 7 6 4% 
OTHER ADVERSE EVENT2 5 3 4% 3 3 4% 8 6 4% 
1 Percentage of patients; 2 One patient in the conventional group had a pleural effusion drained 
associated with surgical rewiring, 1 patient developed a left lung consolidation and an 
episode of ileus, and 1 had sternal oozing, and cellulitis in both legs. In the hybrid group 1 
patient suffered a grand mal seizure, 1 had a convulsion, and 1 patient had haemodynamic 
instability. 
Note. There was one patient who crossed over from hybrid to conventional surgery. This 
patient experienced a stroke as adverse event. 
MI myocardial infarction; SVT supraventricular tachycardia; AF atrial fibrillation; VT 
ventricular tachycardia; VF ventricular fibrillation; CPAP continuous positive airway 
pressure; ARDS Acute respiratory distress syndrome; GI gastrointestinal. Missing data 
(conventional, hybrid): Post-operative MI: 2 (1, 1).   
Table E7 Other Post-operative characteristics 
 
Conventional group 
(n=80) 
Hybrid group 
(n=80) Overall (n=160) 
 n % n % n % 
Post-operative IABP  5 6.3% 6 7.5% 11 6.9% 
 Duration (hours) (Median, IQR) 60.0 (43.0, 157.0) 40.5 (23.0, 61.0) 57.0 (23.0, 67.0) 
Post-operative transfusion (first 24 hours)      
 Red blood cells (products, patients) 99 50 123 53 222 103 
 Fresh frozen plasma (products, 
patients) 
31 11 33 15 64 26 
 Platelets (products, patients) 18 9 42 19 60 28 
 Cryoprecipitate (products, patients) 2 1 2 1 4 2 
Chest reopened 14 17.5% 9 11.3% 23 14.4% 
 Bleeding 10  6  16  
 Low cardiac output 4  2  6  
 Mediastinitis/rewiring 0  1  1  
        
HDU high dependency unit, IQR interquartile range, IABP intra-aortic balloon pump, GTN 
glyceryl trinitrate, SNP sodium nitroprusside 
  
Table E8 Troponin 
 
Randomised to 
Conventional surgery 
(n=67) 
Randomised to 
Hybrid surgery 
(n=71) 
GMR 
(95% CI) P-value 
 Median IQR Median IQR   
Pre-op 13.9 (10.4, 26.9) 14.4 (10.3, 27.0)   
1 hour post-op 614.6 (421, 1130) 756.7 (433, 1360)   
4 hour post-op 861.1 (518, 1425) 847.7 (498, 1422)   
12 hour post-op 652.8 (403, 1029) 778.3 (408, 1209)   
24 hour post-op 554.9 (370, 995) 666.0 (382, 1116)   
48 hour post-op 471.3 (303, 714) 430.1 (298, 746)   
72 hour post-op 411.4 (286, 613) 356.7 (253, 555)   
Test for treatment*time 
interaction 
     0.183 
Overall estimate of treatment 
effect  
    
1.04 
(0.87, 1.24) 
0.675 
Data available for 138 patients, though not all patients have data at all time points. 
Pre-op pre-operative; post-op post-operative; IQR interquartile range; GMR geometric mean 
ratio; CI confidence interval; UK United Kingdom; CABG coronary artery bypass graft 
Missing data at each time point (conventional, hybrid); pre-op (0, 1) 1 hour (0, 1), 4 hours (0, 
2), 12 hours (2, 1), 24 hours (0, 0), 48 hours (0, 3), 72 hours (4,6) 
  
Table E9 Reperfusion Biopsies 
 
Randomised to 
Conventional 
surgery (n=19) 
Randomised to 
Hybrid surgery 
(n=17) 
MD/GMR  
(95% CI) P-value 
 Median IQR Median IQR   
ATP 2.35 (1.65, 3.77) 2.73 (1.60, 3.35) MD= -0.21  
(-0.94, 0.52) 
0.570 
ADP 2.06 (1.47, 2.44) 1.73 (1.00, 2.35) GMR= 0.81 
(0.63, 1.05) 
0.099 
AMP 0.94 (0.40, 1.04) 0.70 (0.41, 0.97) GMR= 0.72 
(0.51, 1.02) 
0.056 
ATP/ADP 1.35 (1.06, 1.58) 1.51 (1.22, 1.81) MD= 0.03  
(-0.28, 0.34) 
0.827 
ATP/AMP 3.13 (2.26, 4.20) 4.17 (2.98, 5.45) MD= 0.73 
(-0.45, 1.91) 
0.206 
Lactate 5.53 (4.08, 8.70) 4.63 (2.88, 8.72) GMR= 0.82 
(0.58, 1.16) 
0.237 
Three patients (2 conventional, 1 hybrid) are omitted from the table due to missing/inaccurate 
reperfusion biopsies. However, they still contributed to the analyses as they had a successful 
control (baseline) biopsy taken.  
ATP adenosine triphosphate; ADP adenosine diphosphate; AMP adenosine monophosphate; 
IQR interquartile range; GMR geometric mean ratio; MD mean difference; CI confidence 
interval; 
